We are live on ! Find out more
BFM

Boothbay Fund Management Portfolio holdings

AUM $7.71B
1-Year Est. Return 106.29%
This Fund
S&P 500
This Quarter Est. Return
+3.85%
1 Year Est. Return
+106.29%
3 Year Est. Return
+266.67%
5 Year Est. Return
+310.43%
10 Year Est. Return
+1,579.99%
AUM
$4.25B
AUM Growth
+$636M
Cap. Flow
+$222M
Cap. Flow %
5.22%
Top 10 Hldgs %
17.16%
Holding
2,498
New
631
Increased
436
Reduced
367
Closed
712

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$119M
2
PFE icon
Pfizer
PFE
+$60.7M
3
CRM icon
Salesforce
CRM
+$48.4M
4
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$20.6M
5
TSLA icon
Tesla
TSLA
+$20.5M

Top Sells

Rank Stock Value
1
DWACU
Digital World Acquisition Corp. Units
DWACU
+$24.6M
2
GOOG icon
Alphabet (Google) Class C
GOOG
+$12.6M
3
SYNH
Syneos Health, Inc. Class A Common Stock
SYNH
+$10.1M
4
HLIT icon
Harmonic Inc
HLIT
+$10.1M
5
FTI icon
TechnipFMC
FTI
+$9.92M

Sector Composition

Rank Sector Weight
1 Financials 10.77%
2 Technology 9.75%
3 Healthcare 8.93%
4 Consumer Discretionary 7.52%
5 Real Estate 3.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BBIG
1726
DELISTED
Vinco Ventures, Inc. Common Stock
BBIG
$62K ﹤0.01%
+1,916
New +$112K
ICCM icon
1727
IceCure Medical
ICCM
$11M
$61K ﹤0.01%
+667
New +$111K
GBRGR
1728
DELISTED
Goldenbridge Acquisition Limited Right
GBRGR
$61K ﹤0.01%
310,317
– –
INSG icon
1729
Inseego
INSG
$121M
$60K ﹤0.01%
+1,033
New +$67.1K
VHC icon
1730
VirnetX Holding Corp
VHC
$63.9M
$60K ﹤0.01%
+1,147
New +$79.6K
PBLA
1731
DELISTED
Panbela Therapeutics, Inc. Common Stock
PBLA
$60K ﹤0.01%
1
– –
CRBP icon
1732
Corbus Pharmaceuticals
CRBP
$177M
$59K ﹤0.01%
3,180
– –
PHUN icon
1733
Phunware
PHUN
$45.8M
$59K ﹤0.01%
+449
New +$69K
ARIZR
1734
DELISTED
Arisz Acquisition Corp. Right
ARIZR
$59K ﹤0.01%
+330,000
New +$51.7K
CYTO
1735
DELISTED
Altamira Therapeutics Ltd
CYTO
$56K ﹤0.01%
77
-24
-24% -$16.1K
DBVT
1736
DBV Technologies
DBVT
$843M
$53K ﹤0.01%
3,286
– –
MNTSW icon
1737
Momentus Inc Warrant
MNTSW
$60
$53K ﹤0.01%
12,597
-1,420
-10% -$2.48K
KPLTW
1738
DELISTED
Katapult Holdings Warrant
KPLTW
$52K ﹤0.01%
15,398
– –
ASMB icon
1739
Assembly Biosciences
ASMB
$526M
$50K ﹤0.01%
1,784
– –
DBGIW
1740
DELISTED
Digital Brands Group, Inc. Warrant
DBGIW
$49K ﹤0.01%
215
– –
HHGCR
1741
DELISTED
HHG Capital Corporation Rights
HHGCR
$46K ﹤0.01%
+125,000
New +$43.9K
LGHLW
1742
DELISTED
Lion Group Holding Ltd. Warrant
LGHLW
$45K ﹤0.01%
33,758
– –
ONCT
1743
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
$45K ﹤0.01%
995
– –
IRD
1744
Opus Genetics
IRD
$312M
$44K ﹤0.01%
11,901
– –
OTIC
1745
DELISTED
Otonomy, Inc.
OTIC
$44K ﹤0.01%
21,048
– –
GYRE icon
1746
Gyre Therapeutics
GYRE
$695M
$42K ﹤0.01%
6,122
– –
ENVB icon
1747
Enveric Biosciences
ENVB
$6.73M
$41K ﹤0.01%
+5
New +$70.3K
UPH.WS
1748
DELISTED
UpHealth, Inc. Warrants exercisable for one share of Common Stock at an exercise price of $115.00 per share
UPH.WS
$41K ﹤0.01%
18,246
-3,230
-15% -$1.19K
SEEL
1749
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
$40K ﹤0.01%
6
– –
MITO
1750
DELISTED
Stealth BioTherapeutics Corp. ADS
MITO
$40K ﹤0.01%
48,397
– –
68 69
70
71 72

Similar funds

MAM
Magellan Asset Management Sydney, Australia $7.71B AUM 11.08% 1-Year Est. Return
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return
WRCM
Whale Rock Capital Management Boston, Massachusetts $7.74B AUM 180.85% 1-Year Est. Return
IMCOOI
Investment Management Corp of Ontario (IMCO) Toronto, Canada $7.76B AUM 99.29% 1-Year Est. Return
CCM
Carronade Capital Management Darien, Connecticut $7.65B AUM 80.26% 1-Year Est. Return
PGFC
Peapack-Gladstone Financial Corp Bedminster, New Jersey $7.82B AUM 21.06% 1-Year Est. Return
AMH
Apollo Management Holdings New York $7.6B AUM 23.97% 1-Year Est. Return
SF
Summit Financial Parsippany, New Jersey $7.85B AUM 20.99% 1-Year Est. Return

Boothbay Fund Management's Q4 2021 Portfolio in Review

As of Q4 2021, Boothbay Fund Management held 2,498 positions worth $4.25B, up 18% from $3.61B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Boothbay Fund Management deployed $222M of net new capital in Q4 2021, opening 631 new positions and adding to 436 existing holdings. Its largest new stake was Pfizer: 1,225,403 shares worth $72.4M.

By sector, the portfolio is most concentrated in Financials at 11% of assets, down from 13% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Alphabet (Google) Class C, an estimated $12.6M trimmed.

  • Boothbay Fund Management's largest Q4 2021 buy was Pfizer: 1,225,403 shares worth $72.4M.
  • Boothbay Fund Management added most to Amazon in Q4 2021, an estimated $119M increase.
  • Boothbay Fund Management's biggest Q4 2021 reduction was Alphabet (Google) Class C, cutting an estimated $12.6M.
  • Boothbay Fund Management fully exited Digital World Acquisition Corp. Units in Q4 2021, selling an estimated $24.6M.
  • Boothbay Fund Management's ten largest holdings make up 17% of its $4.25B portfolio in Q4 2021.
  • Boothbay Fund Management opened 631 new positions and closed 712 in Q4 2021.
  • Boothbay Fund Management's portfolio value rose 18% quarter-over-quarter to $4.25B.

Based on Boothbay Fund Management's 13F filing for Q4 2021, filed 14 Feb 2022.